Stay updated with breaking news from 80067710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) had its target price dropped by research analysts at Stifel Nicolaus from $4.20 to $3.90 in a report released on Friday, The Fly reports. Stifel Nicolaus’ price objective suggests a potential upside of 165.31% from the stock’s current price. A number of other research analysts have also recently weighed […]
Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) had its price objective lowered by Stifel Nicolaus from $4.20 to $3.90 in a research note released on Friday, The Fly reports. A number of other equities analysts have also recently issued reports on the stock. StockNews.com assumed coverage on shares of Sangamo Therapeutics in a research note on […]
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the […]
Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) and Graphite Bio (NASDAQ:GRPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Volatility & Risk Sangamo Therapeutics has a beta of […]